1. Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors

    Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors

    NEWARK, Calif.--(BUSINESS WIRE) -- ​Revance Therapeutics, Inc. (RVNC), a biotechnology company developing a new category of high-performance neuromodulators for use in treating aesthetic and therapeutic conditions, today announced the appointment of Chris Nolet to the company’s Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned